Comparative, Randomized, Double-Blind, Single-Dose, 2-way Crossover Study to Evaluate the Pharmacokinetics and Analgesic Effect of Labopharm Tramadol Contramid® OAD 200 mg Tablets or Placebo in Healthy Young and Elderly Adult Volunteers
This completed clinical trial evaluated the pharmacokinetics and pharmacodynamics of tramadol and its active metabolite, O-desmethyltramadol, in healthy young and elderly adults. The study aimed to understand age-related differences in drug metabolism and analgesic effects, which could inform dosing and safety profiles for geriatric patients.
Indication: Aging
Modality: small molecule
Target: Tramadol and O-desmethyltramadol enantiomers
Sponsor: Université de Montréal
Source URL: ClinicalTrials.gov
Source updated: Dec 31, 2014
Ingested: May 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Tramadol and O-desmethyltramadol enantiomers
View original source fields
Condition raw: Aging
Condition normalized: Aging
Modality raw: Aging
Modality normalized: small molecule
Target raw: Tramadol and O-desmethyltramadol enantiomers
Target normalized: Tramadol and O-desmethyltramadol enantiomers